Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …

Given the expanding indications of transcatheter aortic valve replacement (TAVR) in
younger patients with longer life expectancies, the ability to perform postprocedural coronary …

Since the first-in-human procedure in 2002, transcatheter aortic valve implantation (TAVI)
has become a well-established therapeutic option for severe aortic stenosis, and is offered …

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over
the last decade since the first trials including inoperable or very high risk patients. Thus …

Objectives The aims of this study were to determine the rate of noncentered coronary ostia
and their risk for coronary overlap (CO) and to develop an improved orientation strategy for …

Transcatheter aortic valve implantation (TAVI) is now utilised as a less invasive alternative to
surgical aortic valve replacement (SAVR) across the whole spectrum of surgical risk. Long …

Background Given enough time, transcatheter heart valves (THVs) will degenerate and may
require reintervention. Redo transcatheter aortic valve implantation (TAVI) is an attractive …

In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the
management of aortic stenosis and has become the standard of care regardless of surgical …

Objectives The aim of this study was to investigate the risk of coronary obstruction during
redo–transcatheter aortic valve replacement (TAVR) within a previously implanted self …

Within the last two decades, transcatheter aortic valve replacement (TAVR) has transformed
the treatment strategy for symptomatic severe aortic stenosis (AS), representing a less …